Aquestive Therapeutics, Inc. AQST EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s EV / sales?
- Aquestive Therapeutics, Inc. (AQST) reported EV / sales of 9.2× in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s EV / sales changed year-over-year?
- Aquestive Therapeutics, Inc.'s EV / sales increased by 78.6% year-over-year, from 5.1× to 9.2×.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s EV / sales?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s EV / sales has grown at a 32.0% compound annual growth rate (CAGR), from 4.1× to 16.3×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.